Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision | ||
combating_antibiotic_resistant_bacteria_biopharmaceutical_accelerator [2022/06/06 09:51] liam | — (current) | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ====== Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator ====== | ||
- | {{ :: | ||
- | |||
- | The **Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X)** is a global non-profit partnership accelerating antibacterial products to address drug-resistant bacteria. | ||
- | |||
- | ===== Affiliations ===== | ||
- | |||
- | ==== Funding ==== | ||
- | |||
- | CARB-X is funded by the [[Bill & Melinda Gates Foundation]], | ||
- | |||
- | ==== Global Accelerator Network ==== | ||
- | |||
- | * [[California Life Sciences]] | ||
- | * [[Centre for Cellular and Molecular Platforms]] (C-CAMP) | ||
- | * [[Foundation for Innovative New Diagnostics]] (FIND) | ||
- | * [[German Center for Infectious Diseases]] (DZIF) | ||
- | * [[Institute for Life Sciences Entrepreneurship]] (ILSE) | ||
- | * [[RTI International]] |